Exam Complete Questions And
Verified Answers
\.ICS - Answer- Inhaled corticosteroids used for asthma management.
\.Low ICS - Answer- *Budesonide: 180-360 mcg/day (Pulmicort) and Fluticasone propionate:
100-250 mcg/day (Flovent)
Beclomethasone: 80-160 mcg/day
Mometasone: 110 mcg/day
\.Medium ICS - Answer- • Budesonide: 361-720 mcg/day (Pulmicort )
• Fluticasone propionate: 251-500 mcg/day (Flovent )
• Beclomethasone: 161-320 mcg/day
• Mometasone: 220-440 mcg/day
\.High ICS - Answer- • Budesonide: >720 mcg/day (Pulmicort)
• Fluticasone propionate: >500 mcg/day (Flovent HFA)
• Beclomethasone: >320 mcg/day
• Mometasone: >440 mcg/day
\.SABA - Answer- Short-acting beta agonists such as salbutamol (albuterol) and terbutaline.
, \.LAMA - Answer- Long-acting muscarinic antagonists like tiotropium and beclomethasone-
formoterol glycopyrronium.
\.LABA - Answer- Long-acting beta agonists such as salmeterol and formoterol.
\.ICS and LABA combo - Answer- Combination medications like beclomethasone/formoterol
and budesonide/formoterol.
\.SAMA - Answer- Short-acting muscarinic antagonists such as ipratropium bromide and
oxitropium bromide (combo with SABA).
\.Oral corticosteroids - Answer- Prednisone, prednisolone, and methylprednisolone.
\.Anti-IgE - Answer- Omalizumab, a medication used for asthma management.
\.Leukotriene modifiers (LTRA) - Answer- Medications such as montelukast, pranlukast, and
zileuton.
\.Sustained step-up treatment - Answer- Increase treatment for at least 2-3 months if
symptoms persist despite controller treatment.
\.Common issues to consider before stepping up asthma tx - Answer- Incorrect inhaler
technique, poor adherence, modifiable risk (smoking)
\.Short-term step-up treatment - Answer- Temporary increase in treatment for 1-2 weeks
during exacerbations.